Search by Drug Name or NDC

    NDC 00173-0781-00 LAMICTAL 250 mg/1 Details

    LAMICTAL 250 mg/1

    LAMICTAL is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is LAMOTRIGINE.

    Product Information

    NDC 00173-0781
    Product ID 0173-0781_87724e9e-1329-4f5b-a85e-8d7cf8e6a64c
    Associated GPIs 72600040007545
    GCN Sequence Number 068093
    GCN Sequence Number Description lamotrigine TAB ER 24 250 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 30787
    HICL Sequence Number 007378
    HICL Sequence Number Description LAMOTRIGINE
    Brand/Generic Brand
    Proprietary Name LAMICTAL
    Proprietary Name Suffix XR
    Non-Proprietary Name lamotrigine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name LAMOTRIGINE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022115
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0781-00 (00173078100)

    NDC Package Code 0173-0781-00
    Billing NDC 00173078100
    Package 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0173-0781-00)
    Marketing Start Date 2011-08-15
    NDC Exclude Flag N
    Pricing Information N/A